Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis

View ORCID ProfileZachary J. Williams
doi: https://doi.org/10.1101/2021.07.13.21260452
Zachary J. Williams
1Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, TN
2Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN
4Frist Center for Autism and Innovation, Vanderbilt University, Nashville, TN
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zachary J. Williams
  • For correspondence: Zachary.j.williams{at}vanderbilt.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background and Objectives Strabismus, a misalignment of the eyes, is an important risk factor for amblyopia and visual impairment in the pediatric population. Several studies have reported an increased likelihood of strabismus in persons on the autism spectrum, but prevalence estimates in this group vary greatly.

Methods We searched multiple databases to identify peer-reviewed articles published in English through November 1, 2020 that provided estimates of strabismus prevalence in autistic individuals. Prevalence estimates were synthesized using Bayesian random-effects meta-analysis, and sensitivity analysis was also performed using only the subset of studies that recruited participants from non-ophthalmologic settings and identified strabismus using structured ocular exams. Bayesian meta-regression was used to assess potential moderators of prevalence across studies.

Results A total of 151 nonduplicate articles were screened, of which 22 were included in the meta-analysis (k=28 samples, nAUT=113,227). The meta-analytic point prevalence of strabismus in autistic individuals was 13.4% (95% CrI [8.3,19.4]), and sensitivity analysis produced a very similar estimate (14.0% [7.0,22.0], nAUT=581). Esotropia was the predominant subtype of strabismus reported, accounting for approximately 55% of cases. Reported prevalence rates were higher in younger samples (BF10=13.43, R2Het =0.273) and samples recruited from optometry/ophthalmology clinics (BF10=11.47, R2Het =0.238).

Conclusion This meta-analysis found a high prevalence of strabismus in autistic individuals, with rates 3–10 times that of the general population. As untreated strabismus is a major risk factor for amblyopia in young children, these findings underscore the importance of timely screening and assessment of ocular problems in persons on the autism spectrum.

What’s Known on This Subject Strabismus has been reported to be more prevalent in individuals on the autism spectrum, but estimates have been very imprecise, ranging from 3–84% across studies.

What This Study Adds This study performs the first quantitative synthesis of strabismus prevalence in over 100,000 autistic individuals, generating more precise estimates of the prevalence of strabismus in the autistic population. Factors contributing to the large differences between studies are also examined using meta-regression.

Introduction

Autism spectrum disorder (hereafter “autism”) is a lifelong neurodevelopmental condition characterized by social communication difficulties and repetitive behavior. Individuals on the autism spectrum are known to be at elevated risk for a number of co-occurring medical conditions, most notably epilepsy, gastrointestinal conditions, sleep disorders, and feeding disorders1. Although less well-known, autistic children and adults have high rates of ophthalmologic disorders, with rates as high as 71% across all conditions, including clinically significant refractive errors2.

Strabismus, a misalignment of the eyes, is a common ocular developmental disorder with onset in childhood and sequelae that frequently persist into adulthood3. This condition is present in 2–3% of individuals in the general population4 and can have profound effects on visual function and vision-related quality of life5. It is also a major risk factor for amblyopia, and early treatment of this condition is key to the appropriate development of binocular stereopsis. Over the last several decades, a sizable body of literature has been published on the rate of strabismus in autistic individuals, with one review citing prevalence estimates from 9–60%6. However, there has been no quantitative synthesis of this literature to date, substantially limiting the precision of these estimates. The current study aims to fill this gap in the literature by reporting a systematic review and meta-analysis of the prevalence of strabismus in autistic individuals, as well as the association of strabismus prevalence with a number of demographic and methodological factors.

Methods

A systematic review and meta-analysis was conducted in accordance with PRISMA7 guidelines. We searched PubMed, PsycINFO, PsycARTICLES, CINAHL, ERIC, and for publications on autism that reported rates of strabismus, as defined using the following search terms: (autis* OR asperger* OR PDD*) AND (strabismus OR exotropi* OR esotropi* OR hypertropi*). Results were limited to peer-reviewed journal articles published in English before October 31, 2020. This search was supplemented with a targeted search of the archives of the Journal of Autism and Developmental Disorders using the keyword “strabismus” to detect articles that may have used that word only in a table. All articles included in the meta-analysis were then subjected to forward/backward citation tracing using Google Scholar to identify additional relevant studies (last search conducted November 1, 2020).

We screened titles/abstracts of all publications, using predetermined criteria to select studies for full-text review. All studies selected at this stage included conducted cross-sectional evaluations of autistic individuals that included medical exams, visual function testing, and/or review of medical records. Studies obtained by searching the Journal of Autism and Developmental Disorders archives were automatically all subjected to full-text review. Full-text articles were reviewed for inclusion, with the following criteria: (a) contained at least 20 individuals with diagnosed autism of any age, (b) reported data from which the proportion of autistic individuals with any form of strabismus could be derived. No authors were contacted to request unpublished data. We then extracted data from all articles according to a standardized protocol (available on request). For each included study, we extracted nAUTand nStrabismus, with multiple independent samples within an article being treated as independent studies. Potential study-level moderators were also extracted, including publication year, sample size (log transformed), proportion of females in the sample, proportion of sample with IQ/DQ<70, proportion of sample with a refractive error, mean age, method of strabismus assessment, and whether the sample was recruited from an ophthalmology/optometry clinic. Study quality was also graded using the Hoy risk of bias tool8.

All statistical analyses were performed in R9 using the brms package10. Prevalence estimates were meta-analyzed using a binomial-normal random-effects meta-analysis model with logit link function11, which was fit in a Bayesian framework with weakly-informative priors (Normal(0,10) prior on intercept term and half-Cauchy(0.3) prior on heterogeneity parameter τ). Heterogeneity was quantified using the I2 statistic and the 95% prediction interval12. All model parameters were summarized using the posterior median and 95% highest-density credible interval (CrI). We also conducted a sensitivity analysis, fitting the same meta-analysis model to the subset of prevalence estimates derived from studies that (a) recruited autistic participants from settings other than optometry/ophthalmology clinics, and (b) identified strabismus based on a standardized ocular exam rather than self- or proxy-report. Publication bias was assessed graphically using funnel plots.

Potential moderators of strabismus prevalence (i.e., mean age, proportion female, proportion IQ/DQ<70, proportion with refractive errors, risk of bias score, and sample recruited from optometry/ophthalmology clinic) were assessed using Bayesian meta-regression with a Normal(0,1) prior on standardized regression coefficients. Meta-regression models were compared to the baseline (intercept-only) model using a marginal likelihood-based Bayes factor (BF10). BF10 values >3 provided significant evidence for a moderating relationship, whereas BF10 values <1/3 provided significant evidence against a moderating relationship. Values between 1/3 and 3 were deemed inconclusive. Missing data were handled using 20-fold multiple imputation using the missForest algorithm13.

Results

The initial database search identified 144 non-duplicate records, with an additional 7 records being identified via forward/backward citation tracing. Of these, 71 articles were subjected to full-text review, and 22 were found to meet the inclusion criteria2,14–34 (Figure 1). A full list of included studies can be found in Supplemental Table S1. In total, we extracted prevalence estimates from 28 independent samples, representing data from 113,227 individuals on the autism spectrum (11,697 with strabismus). Estimates of strabismus prevalence ranged from 2.5–84.3% (median 10.6%). Individuals included in the studies were predominantly school-aged children (mean age=8.56 years), 80.2% were male, and 9.7% were also diagnosed with intellectual disability, although demographics varied widely between studies. Though many studies did not report the types of strabismus observed, those that did reported a slight predominance of esotropia (Mdn=55.1%, IQR [43.6,65.6], 16 studies). Most studies showed a moderate risk of bias (Mdn=4, IQR [3.75,5]), with observed scores ranging from 1 (minimal risk of bias) to 8 (high risk of bias) on the 0–10 Hoy scale.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Supplemental Table S1.

Samples included in meta-analysis of strabismus prevalence

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

PRISMA flow diagram detailing the identification, screening and selection of studies for inclusion in the analysis. “Other sources” refers to forward- and backward-searching of included articles using Google Scholar.

Based on our meta-analytic model, the pooled point prevalence of strabismus in the autistic population was 13.4%, CrI95% [8.3,19.4] (Figure 2), with very high heterogeneity (I2=99.3% [98.9,99.7]). This value did not change appreciably when excluding the large population-based study by Chang et al., which contributed 89% of the total sample size (13.5% [8.1,19.9], I2=97.2% [95.5,98.7], nAUT=12,373). A similar estimate was also obtained when limiting our analysis to the nine studies that both recruited individuals from non-ophthalmologic settings and utilized structured eye exams to assess strabismus (14.0% [7.0,22.0], I2=79.3% [55.0,95.9], nAUT=581). The funnel plot of logit-transformed prevalence estimates (Figure 3) was largely symmetrical, suggesting minimal publication bias, although one outlying study17 reported a very high prevalence estimate of 84.3%.

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Posterior density forest plot of strabismus point prevalence in individuals on the autism spectrum. The estimated prevalence and 95% credible interval (CrI) for each study represent the posterior distribution of the prevalence in that sample, conditional on prior beliefs and the observed data. The prediction interval reports the range of prevalence values like to be observed if new studies are conducted. Density values are differentially scaled in order to visualize posterior distribution shapes for all studies. Raw prevalence values from each study can be found in Supplemental Table S1.

Figure 3.
  • Download figure
  • Open in new tab
Figure 3.

Funnel plot of strabismus prevalence estimates. With the exception of a single outlier study (Schulman, 1994, highlighted in red), the plot is relatively symmetrical, indicating little publication bias in this sample of studies.

Bayesian meta-regression indicated a that strabismus prevalence was significantly moderated by mean age, with studies of older individuals reporting lower strabismus prevalence (BF10=13.43, R2Het=0.273). Predicted strabismus prevalence estimates for studies with mean ages of 7.81 and 20.2 years (1 standard deviation below and above the unweighted sample mean age) were 17.4% [11.7,25.0] and 10.0% [6.4,15.1], respectively. The source of the sample was also a significant moderator (BF10=11.47, R2Het =0.238), with samples recruited from optometry/ophthalmology clinics reporting substantially higher rates of strabismus (26.9% [13.3,42.3]) than samples ascertained from other sources (10.2% [6.3,15.0]). Notably, mean age continued to significantly improve the model even after controlling for sample source (BF10=3.28, R2Het =0.360), indicating that the effect of age was not solely due to confounding by clinical samples. None of the other tested variables were significant moderators of study-level prevalence, and Bayes factors indicated substantial evidence against a number of these moderators (Sex ratio: BF10=0.335, proportion with intellectual disability: BF10=0.338, proportion with refractive errors: BF10=0.651, Hoy risk-of-bias score: BF10=0.244).

Discussion

In this study, we performed the first quantitative synthesis of the literature on strabismus in the autistic population, meta-analyzing the prevalence of this condition in over 100,000 individuals on the autism spectrum. Based on our estimates, the overall point prevalence of strabismus in autistic individuals is likely between 8–20%, with similar estimates reported after eliminating a highly-influential study and limiting our analyses to studies of non-ophthalmologic samples tested using standardized ocular exams. While these estimates of co-occurring strabismus are more modest than those produced by many previous studies in autistic samples6, they nevertheless indicate that the prevalence of strabismus in autism is 3–10 times that of the general population. Pediatricians and other clinicians examining autistic individuals should be aware of this increased risk for strabismus and consider referring patients to pediatric ophthalmologists for more comprehensive examinations of ocular pathology.

Strabismus prevalence across studies was moderated both by sample age (lower prevalence in older samples) and sample source (higher prevalence in samples recruited from optometry/ophthalmology clinics), although there was evidence against moderation by sex, proportion of individuals with intellectual disability, and risk-of-bias scores. Perhaps unsurprisingly, samples recruited from ophthalmologic settings had nearly three times the prevalence of strabismus (27%) than samples recruited from other sources (10.2%), confirming prior suspicions that prevalence estimates from many prior studies in autistic individuals are inflated due to biased recruitment6. Studies of older individuals were also likely to report lower strabismus prevalence, potentially due to either medical interventions or spontaneous remission of strabismus with increasing age. However, longitudinal studies of strabismus in autism are necessary to confidently determine the clinical course of strabismus and associated impairments in this population. Notably, a large portion of heterogeneity (64%) remained unexplained after accounting for these two significant moderators, indicating that vast majority of between-study heterogeneity is not attributable to sample demographics or easily quantified study-level variables.

Importantly, this study is not without its limitations. One major limitation was that definitions of strabismus were not standardized across studies, with questionnaires, exam findings, and ICD codes all combined to produce the overall prevalence estimates. However, in our sensitivity analyses, we included studies that only assessed strabismus using ocular exam techniques, which, while somewhat different between studies, were substantially less heterogeneous yet produced a very similar prevalence estimate. Additionally, only one of the included studies33 was truly population-based, and the remainder utilized samples of convenience from community, clinical, or registry sources. Their representativeness of the overall autistic population may vary drastically, biasing the included prevalence estimates. Population-based epidemiologic studies such as large-scale medical record reviews in Nordic countries may further increase the precision of these estimates. As an additional limitation, the reviewed studies did not generally provide information about the degree of strabismus or the rates of amblyopia or other sequelae directly related to strabismus in this population. Future epidemiologic studies of strabismus in autism should specifically attempt to investigate the severity and impact of strabismus in the autistic population, thereby addressing this gap in the literature. Lastly, while our meta-regression failed to find associations between strabismus and factors such as refractive error or intellectual disability, such analyses are substantially underpowered compared to individual participant analyses and should be confirmed with large-sample individual-participant analyses.

Conclusions

In conclusion, our meta-analysis suggests that strabismus is substantially more common in individuals on the autism spectrum than the general population, putting autistic persons at increased risk for amblyopia and other serious sequelae of this condition. The findings of this study highlight the need to screen individuals diagnosed with autism for ocular problems early in life, as early correction of strabismus may significantly decrease the incidence of amblyopia in these individuals and improve overall quality of life35. Further studies of strabismus outcomes in autistic children and adults are necessary to determine whether standard-of-care strabismus treatments remain the most appropriate clinical interventions for individuals in this population.

Data Availability

Original data used in the meta-analysis can be found in the primary articles, as well as supplemental table 1.

Contributors’ Statement

Zachary J. Williams: Mr. Williams conceptualized and designed the study, performed the literature search and article selection, conducted all statistical analyses, and drafted the manuscript. He approves the final manuscript as submitted and agrees to be accountable for all aspects of the work.

Acknowledgements

The author would like to thank the research teams who conducted all primary studies summarized herein, as well as all of the autistic individuals and their families who have contributed to this body of research.

Footnotes

  • Conflict of Interest Disclosures (includes financial disclosures): Zachary Williams has served as a consultant for Roche. He is also a family partner for the Autism Speaks Autism Care Network Vanderbilt site and a member of the autistic researcher review board of the Autism Intervention Research Network on Physical Health (AIR-P).

  • Funding/Support: This study was supported by National Institute of General Medical Sciences grant T32-GM007347, National Institute on Deafness and Other Communication Disorders grant F30-DC019510, and the Nancy Lurie Marks Family Foundation.

  • Role of Funder/Sponsor: No funding body or source of support had a role in the study design, data collection, analysis, or interpretation, decision to publish, or preparation of this article.

Abbreviations

BF10
Bayes factor comparing meta-regression model to baseline model
CrI
Highest-density credible interval
DQ
Developmental quotient
IQ
Intelligence quotient
IQR
Interquartile range
Mdn
Median
nAUT
Number of individuals diagnosed with autism in a study
nStrabismus
Number of autistic individuals diagnosed with strabismus in a study
R2Het
Proportion of heterogeneity explained by moderator

References

  1. 1.↵
    1. McClain MB,
    2. Shahidullah JD,
    3. Mezher KR
    Austin A, Shahidullah JD. Medical Comorbidities in Pediatric Autism Spectrum Disorder. In: McClain MB, Shahidullah JD, Mezher KR, eds. Interprofessional Care Coordination for Pediatric Autism Spectrum Disorder: Translating Research into Practice. Springer International Publishing; 2020:5–13. doi:10.1007/978-3-030-46295-6_2
    OpenUrlCrossRef
  2. 2.↵
    Chang MY, Gandhi N, O’Hara M. Ophthalmologic disorders and risk factors in children with autism spectrum disorder. J Am Assoc Pediatr Ophthalmol Strabismus. 2019;23(6):337.e1-337.e6. doi:10.1016/j.jaapos.2019.09.008
    OpenUrlCrossRef
  3. 3.↵
    Donahue SP. Pediatric Strabismus. N Engl J Med. 2007;356(10):1040–1047. doi:10.1056/NEJMcp051888
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Hashemi H, Pakzad R, Heydarian S, et al. Global and regional prevalence of strabismus: A comprehensive systematic review and meta-analysis. Strabismus. 2019;27(2):54–65. doi:10.1080/09273972.2019.1604773
    OpenUrlCrossRefPubMed
  5. 5.↵
    Hatt SR, Leske DA, Castañeda YS, et al. Association of Strabismus With Functional Vision and Eye-Related Quality of Life in Children. JAMA Ophthalmol. 2020;138(5):528–535. doi:10.1001/jamaophthalmol.2020.0539
    OpenUrlCrossRef
  6. 6.↵
    Little J-A. Vision in children with autism spectrum disorder: A critical review. Clin Exp Optom. 2018;101(4):504–513. doi:10.1111/cxo.12651
    OpenUrlCrossRef
  7. 7.↵
    Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
    OpenUrlCrossRefPubMed
  8. 8.↵
    Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–939. doi:10.1016/j.jclinepi.2011.11.014
    OpenUrlCrossRefPubMed
  9. 9.↵
    R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2020. https://www.R-project.org/
  10. 10.↵
    Bürkner P-C. brms: An R package for Bayesian multilevel models using Stan. J Stat Softw. 2017;80(1). doi:10.18637/jss.v080.i01
    OpenUrlCrossRefPubMed
  11. 11.↵
    Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol. 2008;61(1):41–51. doi:10.1016/j.jclinepi.2007.03.016
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247. doi:10.1136/bmjopen-2015-010247
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–118. doi:10.1093/bioinformatics/btr597
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Knobloch H, Pasamanick B. Some Etiologic and Prognostic Factors in Early Infantile Autism and Psychosis. Pediatrics. 1975;55(2):182–191.
    OpenUrlAbstract/FREE Full Text
  15. 15.
    Rosenberger-Debiesse J, Coleman M. Brief report: Preliminary evidence for multiple etiologies in autism. J Autism Dev Disord. 1986;16(3):385–392. doi:10.1007/BF01531667
    OpenUrlCrossRefPubMed
  16. 16.
    Scharre JE, Creedon MP. Assessment of Visual Function in Autistic Children. Optom Vis Sci. 1992;69(6):433–439.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Schulman RL. Optometry’s role in the treatment of autism. J Optom Vis Dev. 1994;25(4):259–268.
    OpenUrl
  18. 18.
    Kaplan M, Rimland B, Edelson SM. Strabismus in Autism Spectrum Disorder. Focus Autism Dev Disabil. 1999;14(2):101–105. doi:10.1177/108835769901400205
    OpenUrlCrossRef
  19. 19.
    Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM. Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology. 2000;62(6):393–405. doi:10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.0.CO;2-V
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.
    Milne E, Griffiths H, Buckley D, Scope A. Vision in Children and Adolescents with Autistic Spectrum Disorder: Evidence for Reduced Convergence. J Autism Dev Disord. 2009;39(7):965–975. doi:10.1007/s10803-009-0705-8
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.
    Ikeda J, Davitt BV, Ultmann M, Maxim R, Cruz OA. Brief Report: Incidence of Ophthalmologic Disorders in Children with Autism. J Autism Dev Disord. 2013;43(6):1447–1451. doi:10.1007/s10803-012-1475-2
    OpenUrlCrossRefPubMed
  22. 22.
    Singman E, Matta N, Fairward A, Silbert D. Evaluation of plusoptiX Photoscreening During Examinations of Children with Autism. Strabismus. 2013;21(2):103–105. doi:10.3109/09273972.2013.786736
    OpenUrlCrossRefPubMed
  23. 23.
    Black K, McCarus C, Collins MLZ, Jensen A. Ocular Manifestations of Autism in Ophthalmology. Strabismus. 2013;21(2):98–102. doi:10.3109/09273972.2013.786733
    OpenUrlCrossRef
  24. 24.
    McCurry TC, Lawrence LM, Wilson ME, Mayo L. The plusoptiX S08 photoscreener as a vision screening tool for children with autism. J Am Assoc Pediatr Ophthalmol Strabismus JAAPOS. 2013;17(4):374–377. doi:10.1016/j.jaapos.2013.05.006
    OpenUrlCrossRef
  25. 25.
    Neupane S, Bhandari G, Shrestha GS. Ocular Morbidity In Children With Autism. Optom Vis Perform. 2013;1(1):19–24.
    OpenUrl
  26. 26.
    Kabatas EU, Ozer PA, Ertugrul GT, Kurtul BE, Bodur S, Alan BE. Initial Ophthalmic Findings in Turkish Children with Autism Spectrum Disorder. J Autism Dev Disord. 2015;45(8):2578–2581. doi:10.1007/s10803-015-2428-3
    OpenUrlCrossRef
  27. 27.
    Valiente-Pallejà A, Torrell H, Muntané G, et al. Genetic and clinical evidence of mitochondrial dysfunction in autism spectrum disorder and intellectual disability. Hum Mol Genet. 2018;27(5):891–900. doi:10.1093/hmg/ddy009
    OpenUrlCrossRef
  28. 28.
    Sauer T, Lawrence L, Mayo-Ortega L, Oyama-Ganiko R, Schroeder S. Refractive error and ocular findings among infants and young children with severe problem behavior and developmental disabilities. J Ment Health Res Intellect Disabil. 2018;11(4):251–265. doi:10.1080/19315864.2018.1497108
    OpenUrlCrossRef
  29. 29.
    Wang J, Ding G, Li Y, et al. Refractive Status and Amblyopia Risk Factors in Chinese Children with Autism Spectrum Disorder. J Autism Dev Disord. 2018;48(5):1530–1536. doi:10.1007/s10803-017-3387-7
    OpenUrlCrossRef
  30. 30.
    Anketell PM, Saunders KJ, Gallagher SM, Bailey C, Little J-A. Accommodative Function in Individuals with Autism Spectrum Disorder. Optom Vis Sci. 2018;95(3):193–201. doi:10.1097/OPX.0000000000001190
    OpenUrlCrossRef
  31. 31.
    Gebril MMB, Esehiyb BAH. Types of refractive error in autistic children. J Med Sci Clin Res. 2019;7(12):554–558. doi:10.18535/jmscr/v7i12.98
    OpenUrlCrossRef
  32. 32.
    Khanna RK, Kovarski K, Arsene S, et al. Ophthalmological findings in children with autism spectrum disorder. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):909–916. doi:10.1007/s00417-019-04594-7
    OpenUrlCrossRef
  33. 33.↵
    Chang MY, Doppee D, Yu F, Perez C, Coleman AL, Pineles SL. Prevalence of ophthalmologic diagnoses in children with autism spectrum disorder using the Optum dataset: a population-based study. Am J Ophthalmol. Published online September 5, 2020. doi:10.1016/j.ajo.2020.08.048
    OpenUrlCrossRef
  34. 34.↵
    Fombonne E, Green Snyder L, Daniels A, et al. Psychiatric and Medical Profiles of Autistic Adults in the SPARK Cohort. J Autism Dev Disord. 2020;50(10):3679–3698. doi:10.1007/s10803-020-04414-6
    OpenUrlCrossRef
  35. 35.↵
    Ozer PA, Kabatas EU, Bicer BK, Bodur S, Kurtul BE. Does Correction of Strabismus Improve Quality of Life in Children with Autism Spectrum Disorder: Results of a Parent Survey by Ophthalmologists. Semin Ophthalmol. 2018;33(2):149–154. doi:10.1080/08820538.2016.1182559
    OpenUrlCrossRef
Back to top
PreviousNext
Posted July 16, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
Zachary J. Williams
medRxiv 2021.07.13.21260452; doi: https://doi.org/10.1101/2021.07.13.21260452
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
Zachary J. Williams
medRxiv 2021.07.13.21260452; doi: https://doi.org/10.1101/2021.07.13.21260452

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)